Stay updated on Benralizumab in Eosinophilic CRSwNP Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Eosinophilic CRSwNP Clinical Trial page.

Latest updates to the Benralizumab in Eosinophilic CRSwNP Clinical Trial page
- ChecktodayChange DetectedTaoyuan in the study's Locations section is updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333, aligning the site label with the actual geographic designation.SummaryDifference0.0%

- Check7 days agoChange DetectedThe page's revision metadata was updated to v3.5.3, replacing the previous v3.5.2. This reflects a minor version update to the page metadata rather than substantive content changes.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision label updated to v3.5.0; the previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check58 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded Results First Posted for ORCHID with 295 participants and key outcomes (NPS, NBS, DSS, LMS, SNOT-22, CT) at Week 56. Removed older Baseline-to-Week 56 and related outcome entries to reflect the updated data.SummaryDifference2%

Stay in the know with updates to Benralizumab in Eosinophilic CRSwNP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Eosinophilic CRSwNP Clinical Trial page.